Cite
Christensen DH, Horváth-Puhó E, Schmidt M, et al. The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients. Clin Epidemiol. 2015;7:381-9doi: 10.2147/CLEP.S85427.
Christensen, D. H., Horváth-Puhó, E., Schmidt, M., Christiansen, C. F., Pedersen, L., Langdahl, B. L., & Thomsen, R. W. (2015). The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients. Clinical epidemiology, 7381-9. https://doi.org/10.2147/CLEP.S85427
Christensen, Diana Hedevang, et al. "The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients." Clinical epidemiology vol. 7 (2015): 381-9. doi: https://doi.org/10.2147/CLEP.S85427
Christensen DH, Horváth-Puhó E, Schmidt M, Christiansen CF, Pedersen L, Langdahl BL, Thomsen RW. The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients. Clin Epidemiol. 2015 Aug 24;7:381-9. doi: 10.2147/CLEP.S85427. eCollection 2015. PMID: 26346502; PMCID: PMC4554427.
Copy
Download .nbib